A looking glass perspective: thalidomide and cyclopamine.

Cellular and molecular biology (Noisy-le-Grand, France)

Volumn 45, Issue 5, 1999, Pages 579-588

  Gaffield, W ^a   Incardona, J P ^a   Kapur, R P ^a   Roelink, H ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPAMINE; HYPNOTIC SEDATIVE AGENT; PROTEIN; SHH PROTEIN, HUMAN; SONIC HEDGEHOG PROTEIN; TERATOGENIC AGENT; THALIDOMIDE; TRANSACTIVATOR PROTEIN; VERATRUM ALKALOID;

ANIMAL; BIOETHICS; CHEMISTRY; CONGENITAL MALFORMATION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BIOETHICS; HEDGEHOG PROTEINS; HUMANS; HYPNOTICS AND SEDATIVES; PROTEINS; SIGNAL TRANSDUCTION; TERATOGENS; THALIDOMIDE; TRANS-ACTIVATORS; VERATRUM ALKALOIDS;

EID: 0033155823     PISSN: 01455680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)